ULTRALIFE CORP Quarterly Nonoperating Income (Expense) in USD from Q1 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Ultralife Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2016 to Q2 2024.
  • Ultralife Corp Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$71K, a 107% decline year-over-year.
  • Ultralife Corp Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$1.45M, a 756% decline year-over-year.
  • Ultralife Corp annual Nonoperating Income (Expense) for 2023 was -$358K, a 37.7% increase from 2022.
  • Ultralife Corp annual Nonoperating Income (Expense) for 2022 was -$575K, a 209% decline from 2021.
  • Ultralife Corp annual Nonoperating Income (Expense) for 2021 was -$186K, a 114% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$1.45M -$71K -$1.13M -107% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-25
Q1 2024 -$320K -$456K +$38K +7.69% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 -$358K -$536K +$61K +10.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$419K -$386K -$640K -252% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-26
Q2 2023 $221K $1.06M +$1.17M Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-25
Q1 2023 -$952K -$494K -$377K -322% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 -$575K -$597K -$487K -443% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$88K $254K +$253K +25300% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 -$341K -$115K -$94K -448% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 -$247K -$117K -$61K -109% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$186K -$110K -$1.69M -107% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $1.51M $1K +$54K Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 $1.45M -$21K +$96K +82.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-28
Q1 2021 $1.36M -$56K +$36K +39.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $1.32M $1.58M +$1.88M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-08
Q3 2020 -$558K -$53K +$107K +66.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 -$665K -$117K -$34K -41% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 -$631K -$92K -$34K -58.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 -$597K -$296K -$264K -825% Sep 30, 2019 Dec 31, 2019 10-K 2021-02-04
Q3 2019 -$333K -$160K -$181K -862% Jul 1, 2019 Sep 29, 2019 10-Q 2020-10-29
Q2 2019 -$152K -$83K -$169K -197% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-30
Q1 2019 $17K -$58K +$75K +56.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 -$58K -$32K Oct 1, 2018 Dec 31, 2018 10-K 2020-02-06
Q3 2018 $21K Jul 2, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $86K Apr 1, 2018 Jul 1, 2018 10-Q 2019-08-01
Q1 2018 -$133K -$40K -43% Jan 1, 2018 Apr 1, 2018 10-Q 2019-05-02
Q1 2017 -$93K +$20K +17.7% Jan 1, 2017 Apr 2, 2017 10-Q 2018-05-03
Q1 2016 -$113K Jan 1, 2016 Mar 27, 2016 10-Q 2017-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.